MedPath

Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System

Conditions
Male Fertility
Registration Number
NCT00734981
Lead Sponsor
Lotus Bio Inc.
Brief Summary

Evaluation of specificity and sensitivity of Seaforia- an vitro diagnostic system for evaluating semen quality.

Detailed Description

Quantities assessment of semen quality as defined by:

Semen volume, semen pH, leukocytes concentration, sperm cells concentration, motile sperm cell concentration, total motile sperm cells threshold and sperm cells morphology

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • Capable and willing to sign a consent form and participate in the study
  • 20<Age<45
  • Male
Exclusion Criteria

None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Semen Quality as determined by the following parameters: Semen volumeThe same day as sevan evaluation according to the gold standard
Semen pHThe same day as sevan evaluation according to the gold standard
Sperm cells concentrationThe same day as sevan evaluation according to the gold standard
Motile sperm cell concentrationThe same day as sevan evaluation according to the gold standard
Sperm cells morphologyThe same day as sevan evaluation according to the gold standard
Leukocytes concentrationThe same day as sevan evaluation according to the gold standard
Total motile sperm cells thresholdThe same day as sevan evaluation according to the gold standard
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assuta Medical Centers Ltd.

🇮🇱

tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath